Navigation Links
STAAR Surgical to Present at BMO Capital Markets 9th Annual Focus on Healthcare Conference in New York
Date:7/29/2009

MONROVIA, Calif., July 29 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry G. Caldwell, President and Chief Executive Officer will present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel on Wednesday, August 5th at 4:00 pm Eastern Time.

Interested parties can access a live audio web cast of the presentation at www.staar.com. A replay of the presentation will be available at the same location.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian(R) ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at www.staar.com.

    CONTACT:  Investors                       Media
              EVC Group                       EVC Group
              Douglas Sherk, 415-896-6820     Chris Gale 646-201-5431
              Mike Pollock, 415-896-6820


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
2. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
3. STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
4. Richard A. Meier Appointed to STAAR Surgical Board of Directors
5. STAAR Surgical Completes Common Stock Offering
6. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
7. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
8. STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
9. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
10. STAAR Surgical Reports 33% Third Quarter Revenue Growth
11. STAAR Surgical to Present at the Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... , ... April 29, 2016 , ... Dr. Robert Mondavi, ... treatments to improve smiles. Cosmetic dentistry is a fast-growing field as more patients are ... allows patients to learn more about the options currently available to them and which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... their animal line of probiotics, Petbiotics ™, as they fondly call them. ... animal rescue groups networking for their non-profit organizations. Animal rescues across the nation ...
(Date:4/29/2016)... ... April 29, 2016 , ... Intellitec ... held May 16th to 18th at the Broward County Convention Center. The event ... to collaborate on best practices in public facility management. Intellitec Solutions will highlight ...
(Date:4/29/2016)... ... April 29, 2016 , ... In its efforts of bringing ... continues its successful franchise development and expansion as it welcomes Ferdie Vasquez of the ... administrative experience in his 32 years of working in various industries. He had ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016 , Net Sales of ... basis over the prior year period, and an increase of ... , Diluted EPS for the first quarter were $0.52 reported, ... $2.00 adjusted, an increase of 29.9% over the prior year ... adjusted earnings guidance for 2016 Zimmer Biomet Holdings, ...
(Date:4/28/2016)... April 28, 2016 Oramed Pharmaceuticals Inc. ... pharmaceutical company focused on the development of oral drug delivery ... upcoming PIONEERS 2016 conference, presented by Joseph Gunnar ... New York . Nadav Kidron , ... conference. Presentation Details:   PIONEERS ...
(Date:4/28/2016)... Calif. , April 28, 2016 /PRNewswire/ ... Validation Lifecycle Management Solutions (VLMS) today announced ... and services for sufferers of chronic kidney ... System to manage their corporate validation process. ... seeking a software solution to manage their ...
Breaking Medicine Technology: